What question did this study set out to answer?

This research aims to investigate the relationship between colchicine treatment and the prevalence of mitral annular calcification in patients with familial Mediterranean fever.

March 1, 2026

Colchicine-Treated Familial Mediterranean Fever Patients Are Associated With a Lower Prevalence of Mitral Annular Calcification.

Q: What does this research mean for the field?

Colchicine treatment in patients with Familial Mediterranean Fever is associated with a lower prevalence of mitral annular calcification. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Key Result

Colchicine-treated Familial Mediterranean Fever patients showed a lower prevalence of mitral annular calcification, indicating potential cardiovascular protection.

Key Points

This research aims to investigate the relationship between colchicine treatment and the prevalence of mitral annular calcification in patients with familial Mediterranean fever.
Analyzed patients with familial Mediterranean fever receiving colchicine treatment
Examined prevalence of mitral annular calcification
Considered factors related to chronic inflammation
Colchicine-treated patients showed a lower prevalence of mitral annular calcification
Implications point to potential cardiovascular protective effects from reduced chronic inflammation

Structured PICO

Does colchicine reduce the prevalence of mitral annular calcification in patients with Familial Mediterranean Fever?

Population

Patients with Familial Mediterranean Fever

Intervention

Colchicine

Outcome

Prevalence of mitral annular calcificationsurrogate

Colchicine treatment in Familial Mediterranean Fever may offer long-term cardiovascular protection by reducing mitral annular calcification through suppression of chronic inflammation.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Colchicine-treated patients with Familial Mediterranean Fever may be associated with a lower prevalence of mitral annular calcification, suggesting a potential long-term cardiovascular protective effect through suppression of chronic inflammation.

Bookmark

Cite This Study

Cüre et al. (Sun,) reported a other. Colchicine-treated Familial Mediterranean Fever patients showed a lower prevalence of mitral annular calcification, indicating potential cardiovascular protection.

synapsesocial.com/papers/69a3d873ec16d51705d2f4ca https://doi.org/https://doi.org/10.1111/echo.70415

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark